Biography

Molecular biologist and bioengineer driven to translate innovative treatment solutions to patients with limited curative therapies available. Highly experienced modeling human cardiovascular diseases, such as cardiomyopathies, pulmonary fibrosis, and atherosclerosis using stem cell-derived 2D cultures or 3D multicellular organoids in vitro, as well as utilizing mouse models to mimic disease in vivo. Expertise in iPSC biology, automated liquid handling systems, multi-color microscopy, primary human and mouse tissue processing, high throughput systems biology approaches including RNA-seq, scRNA-seq, ChIP-seq, ATAC-seq, cell-based biochemical activity assays, and immunological/histological analyses. Effective in leading interdisciplinary and international collaborative projects as demonstrated by a multitude of high impact publications.